Researchers at the Universidad de Oviedo, Spain, have taken a major step forward in the fight against multiple sclerosis (MS), by demonstrating both genetic and pharmaceutical evidence for the role of a protein called collagenase-2 in the development of the debilitating disease. According to the research team, led by Carlos Lopez-Otin, their findings can provide potential new target for multiple sclerosis therapy.

Collagenase-2 is a member of a protein family called matrix metalloproteinases (MMPs, collagenase-2 is MMP8), which is a large group of enzymes that break down collagen and other components of the body's connective tissue....................

For the full report please go to MSRC: MS Research News : New Discoveries : The Blood Brain Barrier - http://www.msrc.co.uk/index.cfm?fuseaction=show&pageid=1846